US 8252550
Targeting poly-γ-glutamic acid to treat Staphylococcus epidermidis and related infections
granted A61KA61K2039/6037A61K2039/6056
Quick answer
US patent 8252550 (Targeting poly-γ-glutamic acid to treat Staphylococcus epidermidis and related infections) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/6037, A61K2039/6056, A61K2039/6081, A61K39/085